As of Jul 02
| +0.15 / +1.87%|
The 5 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 21.00, with a high estimate of 133.00 and a low estimate of 9.00. The median estimate represents a +157.35% increase from the last price of 8.16.
The current consensus among 6 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.